Eli Lilly and Company: Renal Insufficiency trials
The registry lists 12 Renal Insufficiency studies with Eli Lilly and Company as lead sponsor. 1 are open to participants now and 4 have results posted.
Phase 1 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Tersolisib (LY4064809) in Participants With Kidney Impairment Compared With Participants With Normal Kidney FunctionNot yet recruitingNCT07924930Phase 1
- Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function and Healthy ParticipantsCompletedNCT06190678Phase 1Results posted
- A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.CompletedNCT05936138Phase 1Results posted
- A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal FunctionCompletedNCT05469100Phase 1Results posted
- A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney FunctionCompletedNCT03482024Phase 1Results posted
- A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal FunctionCompletedNCT07426380Phase 1
- A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal ImpairmentCompletedNCT07165015Phase 1
- A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney FunctionCompletedNCT07137689Phase 1
- A Study of LY3819469 in Participants With Impaired and Normal Renal FunctionCompletedNCT05841277Phase 1
- A Study of LY3473329 in Participants With Impaired and Normal Renal FunctionCompletedNCT05778864Phase 1
- A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal FunctionCompletedNCT05611957Phase 1
- A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy ParticipantsWithdrawnNCT03545087Phase 1